Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Total Assets Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual total assets in 2023 was 9.9 Billion CNY , up 10.97% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly total assets in 2024 Q2 was 9.97 Billion CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported annual total assets of 8.92 Billion CNY in 2022, up 24.42% from previous year.
Shanghai Henlius Biotech, Inc. reported annual total assets of 7.17 Billion CNY in 2021, up 11.39% from previous year.
Shanghai Henlius Biotech, Inc. reported quarterly total assets of 9.97 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported quarterly total assets of 9.59 Billion CNY for 2023 Q1, up 7.48% from previous quarter.

Annual Total Assets Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Total Assets of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	9.9 Billion CNY	10.97%
2022	8.92 Billion CNY	24.42%
2021	7.17 Billion CNY	11.39%
2020	6.43 Billion CNY	9.14%
2019	5.89 Billion CNY	90.64%
2018	3.09 Billion CNY	108.47%
2017	1.48 Billion CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	9.97 Billion CNY	0.77%
2024 Q2	9.97 Billion CNY	0.0%
2023 Q1	9.59 Billion CNY	7.48%
2023 Q2	9.59 Billion CNY	0.0%
2023 Q4	9.9 Billion CNY	3.35%
2023 FY	9.9 Billion CNY	10.97%
2023 Q3	9.58 Billion CNY	-0.1%
2022 Q2	8.18 Billion CNY	0.0%
2022 Q4	8.92 Billion CNY	0.0%
2022 Q3	8.92 Billion CNY	9.04%
2022 FY	8.92 Billion CNY	24.42%
2022 Q1	8.18 Billion CNY	14.1%
2021 Q1	6.93 Billion CNY	7.62%
2021 FY	7.17 Billion CNY	11.39%
2021 Q4	7.17 Billion CNY	0.0%
2021 Q3	7.17 Billion CNY	3.5%
2021 Q2	6.93 Billion CNY	0.0%
2020 Q2	5.53 Billion CNY	0.0%
2020 FY	6.43 Billion CNY	9.14%
2020 Q4	6.43 Billion CNY	0.0%
2020 Q3	6.43 Billion CNY	16.31%
2020 Q1	5.53 Billion CNY	-6.17%
2019 FY	5.89 Billion CNY	90.64%
2019 Q1	3.18 Billion CNY	2.79%
2019 Q4	5.89 Billion CNY	0.0%
2019 Q3	5.89 Billion CNY	83.1%
2019 Q2	3.22 Billion CNY	1.29%
2018 Q3	3.09 Billion CNY	0.0%
2018 FY	3.09 Billion CNY	108.47%
2018 Q4	3.09 Billion CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	1.48 Billion CNY	0.0%

Peer Total Assets Comparison of Shanghai Henlius Biotech, Inc.

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-2315.552%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	11.948%